Literature DB >> 6156759

Localization of radioiodinated antibody to alpha-fetoprotein in hepatoma transplanted in rats and a case report of alpha-fetoprotein antibody treatment of a hepatoma patient.

T Koji, N Ishii, T Munehisa, Y Kusumoto, S Nakamura, A Tamenishi, A Hara, K Kobayashi, Y Tsukada, S Nishi, H Hirai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6156759

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Is anti-alphafetoprotein immunoscintigraphy a promising approach for the diagnosis of hepatoma? Implications of a quantitative study in 41 patients.

Authors:  J L Demangeat; L Manil; C Demangeat; E Rico; C Staedel-Flaig; B Duclos; B Brunot; D Jaeck; D Bellet; A Constantinesco
Journal:  Eur J Nucl Med       Date:  1988

2.  Localisation of malignant germ-cell tumours.

Authors:  D S Fairweather; A R Bradwell; P W Dykes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-15

3.  Radioimmunoimaging of tumors with radioactive antibody against a glycoprotein (GP68) found in developing mouse brain.

Authors:  S Kojima; A Awaya; M Ishido; Y Koyama; A Kubodera; Y Hashimoto; H Fukui; H Muramatsu; T Muramatsu
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

4.  Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies.

Authors:  Y Tsukada; E Hurwitz; R Kashi; M Sela; N Hibi; A Hara; H Hirai
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

5.  Clinical observation of (125)I-labeled anti-alpha fetoprotein antibody radioimmunotherapy in hepatocellular carcinoma.

Authors:  Y D Wu; K Z Yang; D N Zhou; Y Q Gang; X Q Song; X H Hu; B Y Huang
Journal:  World J Gastroenterol       Date:  1997-03-15       Impact factor: 5.742

6.  Suppression of human alpha-foetoprotein-producing hepatocellular carcinoma growth in nude mice by an anti alpha-foetoprotein antibody-daunorubicin conjugate with a poly-L-glutamic acid derivative as intermediate drug carrier.

Authors:  Y Tsukada; K Ohkawa; N Hibi
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

7.  Cellular distribution of monoclonal antibody in human tumours after i.v. administration.

Authors:  V Moshakis; R A McIlhinney; A M Neville
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.